Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Evaluate crypto assets based on use case, supply dynamics, and market liquidity to guide beginner-friendly buying decisions for 2024.
26,888 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Verizon Communications stock soaring in 2026 has investors debating its next move. This guide breaks down the drivers...
A practical, plain‑language breakdown of Navigator NVGS's Q1 2026 earnings trajectory. Learn what drives revenue, how...
A dramatic intraday surge in Plug Power stock highlighted the day’s market mood. This article unpacks the catalysts b...
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
The SpaceX IPO dominates chatter, but you don’t have to wait to gain space exposure. Here are three space stocks with...
The 2026 COLA boosted Social Security checks, yet a fixed Medicare premium cut into those gains, changing how retiree...
When a CEO exits at a major fintech-adjacent firm, investors scramble for context. This article digs into what the de...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
As volatility climbs in 2026, a tax-savvy move is drawing attention: converting traditional IRAs to Roth IRAs when va...
The S&P 500 has climbed to new highs, but warning signals are popping up under the surface. This article explains wha...
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...